Cite
HARVARD Citation
Ahn, S. et al. (n.d.). A 96‐week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy. Journal of gastroenterology and hepatology. 31 (4), pp. 865-871. [Online].